A correlational study of ABCA3 and SCN4B as exercise-related biomarkers of patients with Stanford type A aortic dissection

This study identifies ABCA3 and SCN4B as exercise-related biomarkers for Stanford type A aortic dissection, demonstrating their diagnostic potential through a nomogram while elucidating their involvement in circadian rhythm and immune regulation pathways and suggesting zonisamide and MRS1097 as possible therapeutic agents.

The Gist

🏥 The Big Problem: The "Ticking Time Bomb"

Imagine your body's main highway (the aorta) is a massive, high-pressure water pipe. In a condition called Stanford Type A Aortic Dissection (TAAD), the inner lining of this pipe tears. High-pressure water (blood) forces its way between the layers of the pipe wall, causing it to split apart.

This is a medical emergency often called a "ticking time bomb." Without immediate surgery, the pipe can burst, which is often fatal. While we know that moderate exercise (like brisk walking) generally protects the heart, scientists didn't know exactly how exercise stops this specific "pipe splitting" from happening at the molecular level.

🔍 The Detective Work: Finding the "Exercise Clues"

The researchers acted like digital detectives. They didn't just look at the patients; they looked at the blueprints (genes) inside the cells of the aorta.

1. The Data Hunt: They grabbed two massive libraries of genetic data from patients with the dissection and healthy people.
2. The "Exercise" Filter: They had a special list of genes known to react to exercise (like a "fitness playlist"). They asked: "Which genes on this fitness playlist are broken or missing in the patients with the torn pipe?"
3. The Computer Filter: They used powerful computer algorithms (like a super-smart sieve) to narrow down thousands of genes to just the most important ones.

🏆 The Two Heroes: ABCA3 and SCN4B

After all the filtering, two specific genes stood out as the "stars of the show." Let's call them ABCA3 and SCN4B.

• The Bad News: In patients with the aortic tear, these two genes were shut down (their expression was low).
• The Good News: In healthy people, these genes were working hard.
• The Analogy: Think of the aortic wall as a brick wall. ABCA3 and SCN4B are the mortar and the reinforcing steel bars. When exercise happens, it tells the body to make more mortar and steel, keeping the wall strong. In the patients, the "construction crew" stopped working, leaving the wall weak and prone to cracking.

🛠️ What Do These Genes Actually Do?

The researchers dug deeper to see what these genes were doing:

1. The Body's Internal Clock (Circadian Rhythm): These genes are linked to the body's 24-hour clock. Just as your body knows when to sleep and wake up, the aorta needs a rhythm to know when to relax and when to tighten. These genes help keep that rhythm steady.
2. The Immune System Police: The study found that in sick patients, the "bad cops" (inflammatory cells like neutrophils) were swarming the aorta, causing damage, while the "good cops" (naive B cells) were missing.
   • ABCA3 seems to keep the "bad cops" in check.
   • SCN4B seems to help recruit the "good cops."
   • When these genes are low, the "bad cops" run wild, eating away at the pipe wall.
3. The Factory: They are also involved in building ribosomes (the cell's protein factories). Without them, the cells can't repair the damage fast enough.

🩺 The New Tool: A "Smart Calculator" for Doctors

The researchers built a Nomogram. Think of this as a high-tech calculator for doctors.

• Instead of guessing, a doctor can plug in the levels of ABCA3 and SCN4B.
• The calculator spits out a probability score: "99% chance this patient has the dissection."
• This is incredibly accurate (almost perfect), offering a new way to diagnose the disease early before the "bomb" goes off.

💊 The Future: New Medicines?

The study also ran a computer simulation to see if any existing drugs could "fix" these broken genes.

• They found two potential candidates: Zonisamide (usually for seizures) and MRS1097.
• The Metaphor: Imagine the broken gene is a lock that won't turn. These drugs are like special keys that might fit into the lock and force it to work again, potentially strengthening the aortic wall.
• Note: This is just a computer prediction. These drugs haven't been tested on aortic patients yet, but it gives scientists a new starting point.

🧪 The Proof: Lab Tests

To make sure their computer guesses were right, the team took real tissue samples from 5 patients and 5 healthy people. They ran a test (RT-qPCR) and confirmed: Yes, the genes were indeed lower in the sick patients. The computer was right.

🏁 The Bottom Line

This paper tells us that exercise isn't just "good for the heart" in a vague way. It specifically turns on two critical genes (ABCA3 and SCN4B) that act as the glue and the immune shield for your aorta.

• Without exercise: The glue dries up, the immune system gets confused, and the pipe tears.
• With exercise: The glue is reinforced, the immune system stays balanced, and the pipe stays strong.

This discovery gives doctors new tools to diagnose the disease earlier and gives scientists new targets (the genes and the drugs) to try to cure it.

Technical Summary

1. Problem Statement

Stanford Type A Aortic Dissection (TAAD) is a life-threatening cardiovascular emergency with high mortality rates (up to 50% within 48 hours if untreated) and significant surgical risks. While epidemiological evidence suggests that moderate-intensity exercise reduces the incidence of TAAD, the specific molecular mechanisms linking exercise to TAAD pathogenesis remain unclear. There is a critical lack of identified exercise-related biomarkers that could explain how exercise exerts a protective effect, hindering the development of targeted diagnostic tools and therapeutic strategies.

2. Methodology

The study employed a comprehensive bioinformatics-driven approach integrated with experimental validation:

• Data Acquisition:
  • Transcriptomic Data: Bulk RNA-seq datasets (GSE153434 and GSE52093) containing TAAD patient samples and healthy controls were retrieved from the GEO database.
  • Exercise-Related Genes (ERGs): A gene set of 176 ERGs was curated from the MSigDB database based on phenotypic associations with exercise (e.g., exercise intolerance, elevated creatine kinase).
• Differential Expression & Intersection:
  • Differentially Expressed Genes (DEGs) between TAAD and controls were identified using DESeq2.
  • The intersection of DEGs and ERGs yielded 17 Exercise-Related Differentially Expressed Genes (DE-ERGs).
• Machine Learning for Biomarker Selection:
  • Three algorithms were applied to the 17 DE-ERGs to identify robust biomarkers:
    1. LASSO Regression: To shrink coefficients and select features.
    2. SVM-RFE (Support Vector Machine - Recursive Feature Elimination): To iteratively remove less important features.
    3. Boruta Algorithm: To confirm feature importance against shadow features.
  • The intersection of genes selected by all three methods formed the candidate list.
• Diagnostic Modeling: A Nomogram was constructed using the candidate genes to predict TAAD probability, validated via ROC curves, Calibration curves (Hosmer-Lemeshow test), and Decision Curve Analysis (DCA).
• Functional & Mechanistic Analysis:
  • Enrichment Analysis: GO and KEGG pathways were analyzed.
  • GSEA: Gene Set Enrichment Analysis was performed to link biomarkers to specific pathways (e.g., circadian rhythm).
  • Immune Infiltration: CIBERSORT algorithm estimated the abundance of 22 immune cell types and correlated them with biomarker expression.
  • Single-Cell Analysis: Data from the Human Protein Atlas (HPA) was used to determine cell-type specificity of the biomarkers.
  • Regulatory Networks: miRNA-mRNA and lncRNA-miRNA-mRNA networks were predicted using miRDB and ENCORI databases.
  • Drug Prediction: DGIdb was used to identify potential drugs, followed by molecular docking (AutoDock) to verify binding affinity.
• Experimental Validation:
  • RT-qPCR: Expression levels of the final biomarkers were validated in a clinical cohort of 5 TAAD patients and 5 healthy controls using aortic tissue samples.

3. Key Contributions

• Identification of Novel Biomarkers: The study successfully identified ABCA3 and SCN4B as the core exercise-related biomarkers associated with TAAD progression.
• Mechanistic Insight: It elucidated the potential role of these genes in circadian rhythm regulation, ribosome biosynthesis, and immune homeostasis, providing a molecular link between exercise and aortic wall integrity.
• Diagnostic Tool Development: The construction and validation of a high-accuracy Nomogram model incorporating these two biomarkers.
• Therapeutic Hypothesis Generation: The prediction of potential repurposable drugs (Zonisamide and MRS1097) and the mapping of a complex non-coding RNA regulatory network (involving hsa-miR-1343-3p, XIST, hsa-miR-4770, and MALAT1).

4. Key Results

• Biomarker Selection: From the initial 17 DE-ERGs, machine learning converged on ABCA3 and SCN4B. Both genes showed consistent downregulation in TAAD tissues across both public datasets and the clinical validation cohort (RT-qPCR).
• Diagnostic Performance: The Nomogram model demonstrated exceptional diagnostic accuracy with an AUC of 0.990. Calibration curves showed high agreement (HL test P = 0.996), and DCA confirmed superior clinical net benefit compared to individual genes.
• Functional Pathways:
  • Both genes were significantly enriched in circadian entrainment and ribosome biogenesis.
  • Expression levels of ABCA3 and SCN4B were positively correlated with the activity scores of the circadian rhythm pathway.
• Immune Microenvironment:
  • TAAD tissues showed increased infiltration of M0 macrophages, neutrophils, and monocytes, and decreased M1 macrophages and naive B cells.
  • ABCA3 expression was negatively correlated with neutrophil infiltration.
  • SCN4B expression was positively correlated with naive B cell infiltration.
  • Single-cell analysis indicated that these genes are primarily expressed in vascular smooth muscle cells and endothelial cells (not immune cells), suggesting their regulation of the immune microenvironment is indirect.
• Regulatory Network:
  • ABCA3 is regulated by hsa-miR-1343-3p and XIST.
  • SCN4B is regulated by hsa-miR-4770 and MALAT1.
• Drug Prediction:
  • Zonisamide (an antiepileptic) showed strong binding to SCN4B (Binding Energy: -7.3 kcal/mol).
  • MRS1097 (an A3 adenosine receptor antagonist) showed strong binding to ABCA3 (Binding Energy: -5.08 kcal/mol).

5. Significance

• Clinical Utility: The identification of ABCA3 and SCN4B offers a potential early diagnostic signature for TAAD, which is crucial given the disease's rapid lethality.
• Pathophysiological Understanding: The study proposes a novel mechanism where moderate exercise may protect against TAAD by upregulating ABCA3 and SCN4B. This upregulation could stabilize lipid metabolism, maintain vascular smooth muscle cell (VSMC) contractility, regulate ion homeostasis, and modulate the local immune response (reducing neutrophil-mediated inflammation and supporting B-cell function).
• Therapeutic Potential: The identification of Zonisamide and MRS1097 as potential therapeutic agents provides a foundation for drug repurposing strategies. Zonisamide may stabilize sodium channels in VSMCs, while MRS1097 may modulate inflammatory pathways via adenosine receptors.
• Future Directions: While the study is primarily computational with limited wet-lab validation, it establishes a robust framework for future research involving in vivo models to confirm the causal relationship between exercise, these specific genes, and TAAD prevention.

Limitations Noted: The study relies on correlation rather than causation; the "exercise-related" gene set was broad; and the drug predictions require further in vitro and in vivo validation.